-
1دورية أكاديمية
المؤلفون: Rasco, Drew W, Medina, Theresa, Corrie, Pippa, Pavlick, Anna C, Middleton, Mark R, Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S, Daud, Adil I, Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J
المصدر: Cancer chemotherapy and pharmacology. 92(1)
مصطلحات موضوعية: Humans, Neoplasms, Melanoma, Skin Neoplasms, Neoplasms, Second Primary, Proto-Oncogene Proteins B-raf, Mitogen-Activated Protein Kinase Kinases, Protein Kinase Inhibitors, Maximum Tolerated Dose, Adult, BRAF, Pan-RAF inhibitor, Phase 1, Tovorafenib, Clinical Trials and Supportive Activities, Clinical Research, Cancer, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Pharmacology and Pharmaceutical Sciences, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/6jq463hgTest
-
2دورية أكاديمية
المؤلفون: Adjei, Alex A, LoRusso, Patricia, Ribas, Antoni, Sosman, Jeffrey A, Pavlick, Anna, Dy, Grace K, Zhou, Xiaofei, Gangolli, Esha, Kneissl, Michelle, Faucette, Stephanie, Neuwirth, Rachel, Bózon, Viviana
المصدر: Investigational New Drugs. 35(1)
مصطلحات موضوعية: Cancer, Clinical Research, Rare Diseases, Patient Safety, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Adult, Aged, Antineoplastic Agents, Colonic Neoplasms, Extracellular Signal-Regulated MAP Kinases, Female, Humans, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Male, Maximum Tolerated Dose, Melanoma, Middle Aged, Phosphorylation, Protein Kinase Inhibitors, Pyridones, Pyrimidinones, Skin Neoplasms, Treatment Outcome, Uveal Neoplasms, Young Adult, MEK inhibition, Phase 1, Solid tumor, TAK-733, Pharmacology and Pharmaceutical Sciences, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/5w51j54tTest